Efavirenz+emtricitabine+tenofovir Disoproxil
About Efavirenz+emtricitabine+tenofovir Disoproxil
Efavirenz+emtricitabine+tenofovir Disoproxil belongs to the class of medicines called ‘antiretroviral agents’ used to treat HIV infection. HIV is a virus that attacks the immune cells of the body leading to decreased immunity. It spreads through body fluids such as semen, vaginal fluid, and blood. Symptoms include fever, chills, rash, night sweats, muscle aches, tiredness, and sore throat that usually last for days to several weeks.
Efavirenz+emtricitabine+tenofovir Disoproxil contains Efavirenz, Emtricitabine, and Tenofovir. Efavirenz is a non-nucleoside reverse transcriptase inhibitor, whereas Emtricitabine and Tenofovir are nucleotide reverse transcriptase inhibitors. They work by inhibiting the reverse transcriptase enzyme production, which the HIV-infected cells must make to make new viruses. This effect helps to inhibit viral replication.
You should take this medicine exactly as prescribed by the doctor. The common side-effects of Efavirenz+emtricitabine+tenofovir Disoproxil are dizziness, headache, diarrhea, feeling sick (nausea), being sick (vomiting), rashes (red spots or blotches sometimes with blistering and swelling of the skin), and feeling weak. These side-effects usually resolve without requiring any medical attention. However, if any of these side effects persist or get worse, inform your doctor immediately.
It is not recommended to take Efavirenz+emtricitabine+tenofovir Disoproxil if you are allergic to any contents of it. Do not take Efavirenz+emtricitabine+tenofovir Disoproxil if you have severe liver disease, moderate to severe kidney disease, heart condition such as prolongation of the QT interval, which increases the risk of severe heart rhythm problems, family history of heart problems, and low electrolyte levels. It is not recommended for use in children and adolescents under 18 years of age. It should be used with caution in pregnant women, breastfeeding mothers, and elderly people. Consumption of alcohol may increase the risk of side effects. Efavirenz+emtricitabine+tenofovir Disoproxil may cause dizziness, so do not drive or operate heavy machinery if you feel dizzy.
Uses of Efavirenz+emtricitabine+tenofovir Disoproxil
Medicinal Benefits
Efavirenz+emtricitabine+tenofovir Disoproxil belongs to the group of medicines called antiretroviral therapy (ART). Efavirenz+emtricitabine+tenofovir Disoproxil is a fixed-dose combination (FDC) and contains Efavirenz, Emtricitabine, and Tenofovir. FDC helps decrease drug resistance (reducing medication effectiveness) as the HIV virus can easily develop drug resistance. Efavirenz+emtricitabine+tenofovir Disoproxil helps reduce the symptoms, control the infection, and prevent opportunistic infections effectively. It further helps in improving the quality of life of a patient with HIV.
Directions for Use
Storage
Side Effects of Efavirenz+emtricitabine+tenofovir Disoproxil
- Dizziness
- Headache
- Diarrhea
- Feeling sick (nausea)
- Being sick (vomiting)
- Rashes (red spots or blotches sometimes with blistering and swelling of the skin)
- Feeling weak
- Loss of appetite
- Difficulty sleeping, abnormal dreams, difficulty concentrating, drowsiness
- Feeling worried or depressed
Patients Concern
Disease/Condition Glossary
HIV infection: HIV (human immunodeficiency virus) is a virus that attacks the immune system, making the individual susceptible to other infections or illnesses. People with HIV experience flu-like symptoms such as fever, chills, rash, night sweats, muscle aches, tiredness, and sore throat. These symptoms usually last for days to several weeks. It spreads through body fluids such as semen, vaginal fluid, and blood. If left untreated, this condition can lead to AIDS (Acquired Immunodeficiency Syndrome). It is a life-long condition, and there is no definite cure for it. However, it can be controlled by treating with antiretroviral agents.
FAQs
Efavirenz+emtricitabine+tenofovir Disoproxil contains Efavirenz, Emtricitabine, and Tenofovir. Efavirenz is a non-nucleoside reverse transcriptase inhibitor, whereas Emtricitabine and Tenofovir are nucleotide reverse transcriptase inhibitors. They work by inhibiting the reverse transcriptase enzyme production, which the HIV-infected cells must make to make new viruses. This effect helps to inhibit viral replication.
Efavirenz+emtricitabine+tenofovir Disoproxil should be taken on an empty stomach 1 hour before or 2 hours after a meal, preferably at bedtime, as this medicine may cause dizziness or drowsiness.
The common side-effects of Efavirenz+emtricitabine+tenofovir Disoproxil are dizziness, headache, diarrhea, feeling sick (nausea), being sick (vomiting), rashes (red spots or blotches sometimes with blistering and swelling of the skin), and feeling weak. These side-effects usually resolve without requiring any medical attention. However, if any of these side effects persist or get worse, inform your doctor immediately.
Efavirenz+emtricitabine+tenofovir Disoproxil should not be given to patients with severe liver disease, moderate to severe kidney disease, heart condition such as prolongation of the QT interval which increases the risk of severe heart rhythm problems, family history of heart problems, and low electrolyte levels.
Efavirenz+emtricitabine+tenofovir Disoproxil doesn’t cure HIV infection. However, it helps to control the disease and prevent opportunistic infections.
